BiomX Inc.
PHGE
$4.60
$0.092.00%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.41M | 2.42M | 2.51M | 6.03M | 3.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.54M | 7.43M | 7.76M | 8.51M | 10.53M |
| Operating Income | -8.54M | -7.43M | -7.76M | -8.51M | -10.53M |
| Income Before Tax | -9.16M | -6.04M | -7.66M | -14.51M | 9.64M |
| Income Tax Expenses | 3.00K | 2.00K | 1.00K | 3.00K | -- |
| Earnings from Continuing Operations | -9.17M | -6.04M | -7.66M | -14.51M | 9.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.17M | -6.04M | -7.66M | -14.51M | 9.64M |
| EBIT | -8.54M | -7.43M | -7.76M | -8.51M | -10.53M |
| EBITDA | -7.30M | -7.14M | -7.52M | -7.59M | -10.21M |
| EPS Basic | -5.55 | -3.66 | -6.30 | -15.11 | 5.88 |
| Normalized Basic EPS | -3.47 | -2.29 | -3.94 | -4.13 | 7.58 |
| EPS Diluted | -5.55 | -3.66 | -6.30 | -16.85 | 5.88 |
| Normalized Diluted EPS | -3.47 | -2.29 | -3.94 | -4.13 | 7.58 |
| Average Basic Shares Outstanding | 1.65M | 1.65M | 1.22M | 960.30K | 861.40K |
| Average Diluted Shares Outstanding | 1.65M | 1.65M | 1.22M | 960.30K | 861.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |